MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, ...
The company said its EscharEx treatment had previously demonstrated its ability to effectively and rapidly remove damaged or ...
YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...
A new device for meibomian gland debridement was safe and effective and demonstrated time and space benefits compared with conventional debridement and expression approaches, according to a study ...
The OKC Thunder found a way to thrive via committee during the absence of Chet Holmgren, who returned in a win over Toronto ...
Taking proper care of your teeth is quite possibly one of the most important things you can do for your health. After all, it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results